NEW YORK, April 19 (GenomeWeb News) - Genomatica has signed a software licensing and development deal with DSM, a Dutch chemical and biotechnology firm, the company said today.
Under the agreement, DSM will license SimPheny, Genomatica's modeling and simulation platform, to use for strain engineering, process development, and other research areas. In addition, the two companies will jointly develop a metabolic model of production organism for SimpPheny.
San Diego-based Genomatica will receive undisclosed licensing fees and milestone payments.